APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON AUGUST 7, 2019By ApyxMedical|2025-12-12T19:45:55+00:00July 2, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION JOINS RUSSELL 3000® AND RUSSELL 2000® INDEXESBy ApyxMedical|2025-12-12T19:46:18+00:00July 1, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEBy ApyxMedical|2025-12-12T19:46:39+00:00June 4, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:47:02+00:00May 8, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOKBy ApyxMedical|2025-12-12T19:47:27+00:00April 1, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019By ApyxMedical|2025-12-12T19:47:50+00:00April 1, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS AND INTRODUCES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:48:15+00:00March 13, 2019|2019 Shareholder News, J-Plasma|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 13, 2019By ApyxMedical|2025-12-12T19:48:36+00:00February 7, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES THE PROMOTION OF TODD HORNSBY TO EXECUTIVE VICE PRESIDENTBy ApyxMedical|2025-12-12T19:48:59+00:00January 14, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2018 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:49:19+00:00January 7, 2019|2019 Shareholder News, J-Plasma, Renuvion|
Bovie Medical Corporation Files 510(K) Submission with the FDA for a New Indication to Market and Sell J-PLASMA/RENUVION for use in Dermal Resurfacing ProceduresBy ApyxMedical|2025-12-12T19:49:44+00:00December 21, 2018|2018 Shareholder News, J-Plasma|
Bovie Medical Corporation Announces Appointment of Tara H. Semb as Chied Financial OfficerBy ApyxMedical|2025-12-12T19:50:07+00:00December 17, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES CORPORATE NAME CHANGE TO APYX MEDICAL CORPORATION AND PLANS TO TRANSITION COMMON STOCK LISTING TO NASDAQ GLOBAL SELECT MARKETBy ApyxMedical|2026-01-14T22:13:03+00:00December 12, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION TO PARTICIPATE IN THE PIPER JAFFRAY 30TH ANNUAL HEALTHCARE CONFERENCEBy ApyxMedical|2025-12-12T19:50:49+00:00November 19, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION ANNOUNCES FUTURE RETIREMENT OF JAY D. EWERS, CHIEF FINANCIAL OFFICER, TREASURER AND SECRETARYBy ApyxMedical|2025-12-12T19:51:12+00:00November 13, 2018|2018 Shareholder News, J-Plasma|
BOVIE MEDICAL CORPORATION REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2018 OUTLOOKBy ApyxMedical|2025-12-12T19:51:36+00:00November 1, 2018|2018 Shareholder News, J-Plasma|
